Drugs / liposomal cytarabine
last change Oct 2014 re-read 3 minutes ago

liposomal cytarabine

Developed for
breast carcinoma · malignant tumor of meninges · metastatic malignant neoplasm in the brain
Investigated by
National Cancer Institute (NCI) · University of Washington

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00992602 Apr 2011 → Jun 2013 breast carcinoma, malignant tumor of meninges, metastatic malignant neoplasm in the brain University of Washington Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as liposomal cytarabine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00992602 ↗
Route Intrathecal “Given IT or via LP” NCT00992602 ↗